Urgent.News

What's breaking now, across thousands of outlets.

Finance & Markets

Electra's $350M IPO will help it become a commercial biotech

Electra Therapeutics became the 21st biotech of 2026 to go through with an IPO after pricing its $350 million Nasdaq debut on Thursday evening. The Bay Area biotech will use the ...

We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.

This story

This is one outlet's version. Read the fullest account.

Read the original at endpoints.news →

More in Finance & Markets

More from Friday 18 September →